Poly (D,L-lactide-co-glycolide) nanoparticles loaded with linamarin as a model drug were successfully prepared using the double emulsion solvent evaporation technique. The physicochemical characterization of the formulated nanoparticles revealed that they were spherical, nonaggregated, and negatively charged, with good drug encapsulation efficiencies (>50%) and average particle sizes <200 nm. Interestingly, all the nanoparticles exhibited dibasic release profiles with a starting burst release within the first 8 h, followed by a controlled release phase lasting four days. Thus, linamarin-loaded nanoparticles indicate a promising candidate for controlled drug release applications
Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires stre...
International audienceThis study describes how the control of doxorubicin (DOX) polarity allows to e...
The utility of polymeric nanoparticles as drug delivery systems depends on effective control of synt...
Purpose: To formulate and evaluate glibenclamide (GB)-loaded poly(lactic-co-glycolic) acid (PLGA) na...
In recent years, there have been a plethora of nanoengineering approaches for the development of pol...
Purpose: To formulate and evaluate glibenclamide (GB)-loaded poly(lactic-co-glycolic) acid (PLGA) na...
Nanoparticulate drug delivery systems have the potential to allow delivery of diagnostic and therape...
Polymeric microparticles (MPs) are recognized as very popular carriers to increase the bioavailabili...
The objective of this study was to analyze different formulation and process parameters and its infl...
Background: Poly lactide-co-glycolide (PLGA) nanoparticles (NPs) have been widely used in drug deliv...
Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) and PLGA-based polymeric nanoparticles are wid...
Poly(lactide-co-glycolide) (PLGA) is a biodegradable and biocompatible synthetic aliphatic polyester...
The objective of this study was to develop biodegradable poly (DL-lactide-co-glycolic acid) (PLGA) n...
Long-term drug delivery has advantages over traditional drug delivery, including better patient comp...
Poly(D,L-lactic-co-glycolic acid) (PLGA) is an important material used in drug delivery when control...
Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires stre...
International audienceThis study describes how the control of doxorubicin (DOX) polarity allows to e...
The utility of polymeric nanoparticles as drug delivery systems depends on effective control of synt...
Purpose: To formulate and evaluate glibenclamide (GB)-loaded poly(lactic-co-glycolic) acid (PLGA) na...
In recent years, there have been a plethora of nanoengineering approaches for the development of pol...
Purpose: To formulate and evaluate glibenclamide (GB)-loaded poly(lactic-co-glycolic) acid (PLGA) na...
Nanoparticulate drug delivery systems have the potential to allow delivery of diagnostic and therape...
Polymeric microparticles (MPs) are recognized as very popular carriers to increase the bioavailabili...
The objective of this study was to analyze different formulation and process parameters and its infl...
Background: Poly lactide-co-glycolide (PLGA) nanoparticles (NPs) have been widely used in drug deliv...
Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) and PLGA-based polymeric nanoparticles are wid...
Poly(lactide-co-glycolide) (PLGA) is a biodegradable and biocompatible synthetic aliphatic polyester...
The objective of this study was to develop biodegradable poly (DL-lactide-co-glycolic acid) (PLGA) n...
Long-term drug delivery has advantages over traditional drug delivery, including better patient comp...
Poly(D,L-lactic-co-glycolic acid) (PLGA) is an important material used in drug delivery when control...
Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires stre...
International audienceThis study describes how the control of doxorubicin (DOX) polarity allows to e...
The utility of polymeric nanoparticles as drug delivery systems depends on effective control of synt...